Cerebral glioblastoma
Showing 1 - 25 of 6,067
Glioblastoma Trial (Tislelizumab and Bevacizumab)
Not yet recruiting
- Glioblastoma
- Tislelizumab and Bevacizumab
- (no location specified)
Apr 12, 2023
Glioblastoma Multiforme Trial (5-Aminolevulinic Acid)
Not yet recruiting
- Glioblastoma Multiforme
- 5-Aminolevulinic Acid
- (no location specified)
Jan 16, 2023
Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab)
Recruiting
- Glioblastoma Multiforme
- Anaplastic Astrocytoma
-
New York, New YorkLenox Hill Brain Tumor Center
Nov 10, 2022
Glioblastoma, Malignant Glioma Trial in Duarte (Azeliragon, Biospecimen Collection, Computed Tomography)
Not yet recruiting
- Glioblastoma
- Malignant Glioma
- Azeliragon
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 6, 2023
Glioblastoma Multiforme, Brain Tumor Trial in New York (Bevacizumab)
Active, not recruiting
- Glioblastoma Multiforme
- Brain Tumor
-
New York, New YorkLenox Hill Brain Tumor Center
Jun 20, 2022
Glioblastoma, Glioblastoma Multiforme, Glioma, Malignant Trial in New York (Repeated Superselective Intraarterial Cerebral
Recruiting
- Glioblastoma
- +6 more
- Repeated Superselective Intraarterial Cerebral infusion (SIACI) of Bevacizumab (Avastin) with Temozolomide and Radiation
- Temozolomide and Radiation Alone
-
New York, New YorkLenox Hill Brain Tumor Center
May 5, 2022
High Grade Glioma, Glioma, Glioma, Malignant Trial in Phoenix (Temsirolimus)
Not yet recruiting
- High Grade Glioma
- +3 more
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
Mar 6, 2023
Differentiation Between Healthy Cerebral Tissue and Tumor Tissue
Active, not recruiting
- Glioblastoma
- Surgical Margin
- Diffuse Reflectance Spectroscopy
-
Stockholm, SwedenKarolinska University Hospital
Dec 11, 2021
Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab and Carboplatin)
Suspended
- Glioblastoma Multiforme
- Anaplastic Astrocytoma
- Bevacizumab and Carboplatin
-
New York, New YorkLenox Hill Brain Tumor Center
Oct 27, 2021
Automatic Segmentation MRI Cerebral Glioma
Not yet recruiting
- Cerebral Glioblastoma
- MRI
- (no location specified)
Dec 14, 2020
Supratentorial Tumors, Malignant, Malignant Glioma, Glioblastoma Trial in Birmingham, Columbus (G207)
Active, not recruiting
- Supratentorial Neoplasms, Malignant
- +6 more
- G207
-
Birmingham, Alabama
- +1 more
Jun 1, 2022
Glioblastoma, Cerebral Edema, Chemo Effect Trial in Lund (Salovum)
Completed
- Glioblastoma
- +2 more
- Salovum
-
Lund, SwedenDepartment of Neurosurgery
Apr 27, 2021
Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Super-Selective Intraarterial Intracranial Infusion of
Completed
- Glioblastoma Multiforme
- Anaplastic Astrocytoma
- Super-Selective Intraarterial Intracranial Infusion of Temozolomide
-
New York, New YorkLenox Hill Brain Tumor Center
Mar 2, 2021
Childhood Choroid Plexus Tumor, Childhood Ependymoblastoma, Childhood Grade III Meningioma Trial in United States (palbociclib
Terminated
- Childhood Choroid Plexus Tumor
- +18 more
- palbociclib isethionate
- +2 more
-
Los Angeles, California
- +10 more
Feb 10, 2021
Recurrent Glioblastoma, Refractory Glioblastoma Trial in Hangzhou, Huzhou, Ningbo (Temozolomide, B7-H3 CAR-T)
Recruiting
- Recurrent Glioblastoma
- Refractory Glioblastoma
- Temozolomide
- B7-H3 CAR-T
-
Hangzhou, Zhejiang, China
- +2 more
Dec 25, 2022
Malignant Brain Tumors Trial in Berkel en Rodenrijs (procedure, device, other)
Recruiting
- Malignant Brain Tumors
- intra-arterial injection
- +2 more
-
Berkel en Rodenrijs, Zuid Holland, NetherlandsLaurens Groenendijk
Apr 3, 2023
Glioblastoma Multiforme, Glycolytic Index, Epidermal Growth Factor Receptor Trial (pH Measurement of in vivo tissue)
Not yet recruiting
- Glioblastoma Multiforme
- +2 more
- pH Measurement of in vivo tissue
- (no location specified)
Sep 26, 2023
Glioblastoma Trial in Strasbourg (Simultaneous-integrated boost with IMRT)
Not yet recruiting
- Glioblastoma
- Simultaneous-integrated boost with IMRT
-
Strasbourg, FranceInstitut de cancérologie Strasbourg Europe
Dec 7, 2022
Glutamate Excitotoxicity and Its Role in Glioblastoma Biology
Recruiting
- Brain Tumor, Primary
- Blood, CSF and tumor samples
-
Milan, ItalyIRCCS San Raffaele Scientific Institute
Mar 16, 2023
Recurrent Glioblastoma Trial in Miami (Intensity Modulated Proton Therapy (IMPT), Bevacizumab)
Recruiting
- Recurrent Glioblastoma
- Intensity Modulated Proton Therapy (IMPT)
- Bevacizumab
-
Miami, FloridaUniversity of Miami
Sep 30, 2022
Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (other, biological, procedure)
Active, not recruiting
- Recurrent Glioblastoma
- Recurrent Gliosarcoma
- Laboratory Biomarker Analysis
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 19, 2022
Glioblastoma, Recurrent Glioblastoma, GBM Trial in Santa Monica (Radiation: Intra-operative Radiation Therapy - IORT,
Recruiting
- Glioblastoma
- +3 more
- Radiation: Intra-operative Radiation Therapy - IORT
- +2 more
-
Santa Monica, CaliforniaProvidence Saint John's Health Center
Jul 14, 2022
Ependymoma, Glioblastoma, Medulloblastoma Trial in Duarte (IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR
Recruiting
- Ependymoma
- +3 more
- IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR Truncated CD19-expressing Autologous T-Lymphocytes
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 9, 2022